Logo InsideTx 2024
  • Products
    • TAMARA:
      LNP & Nanoparticle Formulation System
    • Proof-of-Concept & Training
    • Custom Platform
  • Resources
    • Nano Reviews
    • Nanomed News
    • Publications
    • Application Notes
    • RNA-LNP Formulation Calculator
  • About us
CONTACT US
  • Home
  • Products
  • Resources
  • Training & Proof-of-Concept
  • About us
  • Distributors and partners

We bridge the gap
between patients and
RNA-LNP therapeutics promises

We bridge the gap
between patients and
RNA-LNP therapeutics promises

How do we do it ?

Leveraging our patented technology, our formulation systems unlock the 3 main bottlenecks in the existing nanoparticle manufacturing process by:

        • Minimizing screening cost & efficiency
        • Ensuring scalability throughout the drug development process
        • Unlocking large-scale continuous production

We are developing the only streamlined nanoparticle synthesis platform that accelerates your screening to production time while maximizing the chances of success of your drug development.

VISION

The convergence of genetics and nanotechnologies is enabling breakthrough therapies for infectious & genetic diseases and cancers.

MISSION

We strive to provide state-of-the art instruments & services for demanding labs, biotechs & pharmas to streamline the development of their nanomedicines.

OUR STORY

 

Inside Therapeutics has been founded in 2022 by an experienced team, with a complementary background in biotechnology, nanoparticles, engineering, marketing, business and entrepreneurship.

In less than 18 months, we designed, developped and launched our first nanoparticle formulation system: TAMARA

Yet, this is only the first step of our journey! Stay tuned 🙂

Leadership

Alexis Peyroles

Cofounder & Chairman

Click to access bio

Thomas Guerinier

Cofounder & CEO

Click to access bio

Matthieu Kerhuel

Cofounder & CTO

Click to access bio

Audrey Nsamela

Cofounder & CSO

Click to access bio

Robin Oliveres

Cofounder & CBO

Click to access bio

Board

Alexis Peyroles

Inside Tx

Click to access bio

Guilhem Velve Casquillas

Microfluidic Inno. Center

Click to access bio

Thomas Guerinier

Inside Tx

Click to access bio

Julie Roblot

Newfund Naeh

Click to access bio

Anne-Sophie Saint-Martin

Newfund Heka

Click to access bio

Yvan Cantou

Skalepark

Click to access bio

Inside Therapeutics by the numbers

50+

Companies & universities trust us

20

Employees

4

Patents

Investors

Partners & supports

BPI France
EUREKATECH
French Tech
Aquitaine Amorcage
Region Nouvelle aquitaine

BPI France, the French Public Bank for Investment labelled our project as Deeptech. This label recognizes innovations that pushes the frontiers of science and technical limitations.

This increases the project visibility and opens non-dilutive funding opportunities.

The Region Nouvelle Aquitaine through its Start-up Service gives a significant boost to the project.

The financial support provided by the Regional Government will empower Inside Tx to accelerate research and development efforts and attract top-tier talent.

Where to find us ?

Head office
25 rue de la Grand Font
16000 Angoulême, France

Bordeaux office
2 rue Marc Sangnier
33130 Bègles, France

Paris office
14 rue Soleillet
75020 Paris, France

Logo InsideTx 2024 White
  • Home
  • Products
  • Resources
  • Training & Proof-of-Concept
  • About us
  • Distributors and partners
Contact us

contact@insidetx.com
© Inside Tx 2025

Alexis Peyroles - Co-founder & chairman

 

 

ALEXIS PEYROLES

CFO & cofounder

Linkedin

Alexis is an EDHEC Business School (1996) graduate, he holds an MBA (2008, Imperial College London), and has accumulated more than 25 years of experience in the biotech field.

In 2014, he joined the biotech OSE Immunotherapeutics as Director of Operations. He led the business development with pharmaceutical companies and built the financing plan until an IPO (Euronext) in 2015 allowing a financing of 21 million euros for the company. Alexis became the CEO of OSE Immunotherapeutics in 2018 and continued the company's development by signing immunotherapy development licenses with Servier, Boehringer Ingelheim and Veloxis and securing the company's drug development pipeline.

At Inside Therapeutics, Alexis acts as CFO and chairman of the board

 

 

THOMAS GUERINIER

CEO & cofounder

Linkedin

Thomas owns a PhD in biology (2012, Université Paris-Saclay) and a master degree in Innovation Management.

He joined Cherry Biotech straight at its founding (2014), an Elvesys spin-off specialized in organoids and organ-on-a-chip instruments and services. He managed various functions including industrialization, administration, innovative project management, financial and scientific reports as well as sales and marketing structuration.

He handled a deputy CEO position from 2017 to 2019. From 2019 to 2022, he joined Elvesys as CMO and Codir member with a particular mission of transition management during a scale-up momentum of the company (x2 turnover and employees).

He currently is the CEO of Inside Therapeutics

Audrey

 

 

AUDREY NSAMELA

CSO & cofounder

Linkedin

Audrey is a nanoparticle Ph.D. graduate. She originally has a physics engineering background from the University of Louvain, before specializing in nanotechnologies and bioengineering at Polytechnique Montreal.

During her PhD, she specifically studied the nucleation and physics of lipid nanoparticles and liposome formation. Her work led to the patent at the heart of Inside Therapeutics' project.

Audrey is the Chief Scientific officer at Inside Therapeutics

Robin

 

 

ROBIN OLIVERES

CBO & cofounder

Linkedin

Robin is a micro/nanotechnology engineer, who graduated from a dual degree between INP Grenoble/EPFL in 2015. His solid initial training took him to the United States (Georgia Institute of Technology, IBM San Francisco). Robin quickly oriented his career towards technical sales and business, first at Resolution Spectra Systems until 2017 before heading to Hong Kong where he worked to identify business partners for French tech companies.

He joined Elvesys in 2018 and successfully expressed his dual technical and business skills as a sales engineer. He took over the head of sales position in 2019, with which Elvesys will double its turnover between 2020 and 2022.

He currently holds the Chief Business Officier position at Inside Therapeutics.

 

 

MATTHIEU KERHUEL

CTO & cofounder

Linkedin

Matthieu is a Fluid Mechanics and Automation engineer by trade who graduated from Ecole Centrale (1999, Lyon).

He held financial engineering positions from 2001 to 2009 throughout Europe and the United States. Matthieu then returned to France and joined the Ecole Centrale in Nantes to do his thesis work in numerical simulation applied to fluid mechanics.

He then seized an entrepreneurial opportunity and founded Advanced Aerodynamic Vessels in 2013, which he managed until 2022. He handled the whole project (structuring, fund raising, R&D...) as CEO until the realization of a functional prototype and the delivery of 3 innovative commercial ships (fast and low energy consumption).

He currently is the CTO of Inside Therapeutics

 

 

YVAN CANTOU

SkalePark

Linkedin

With a background in engineering, Yvan's expertise lies not only in new technologies, but also in finance and business management.

After many years as CFO and founding his own start-up, he is now one of SkalePark's key representatives. It's his ability to build strong relationships with entrepreneurs and his vision on innovation issues that makes SkalePark stand out and shine on the Bordeaux scene. A real asset for your tech/deep tech fund-raising projects, he will be able to advise you concretely and provide you with strategic solutions that will give impetus to your development.

 

 

ANNE-SOPHIE SAINT-MARTIN

Newfund Heka

Linkedin

Trained as an engineer, Anne-Sophie started her career as a scientist in a biotech company, Cyclene Pharmaceutical, before joining Solvay’s polyamide team as an innovation analyst working with the marketing team.

Then she joined Bpifrance where she financed through loans and guarantees many start-ups in the Paris region.

Guilhem Velve Casquillas - Elvesys CEO & Founder

 

 

GUILHEM VELVE CASQUILLAS

Microfluidic Innovation Center

Linkedin

Guilhem is a entrepreneur, researcher & enthusiastic. he co-founded over 10 tech start-ups and follows his journey as CEO of the Microfluidic Innovation Center.

 

 

JULIE ROBLOT

Newfund Naeh

Linkedin

Julie started her career in private banking and then moved to London to pursue an EMBA at ESCP Business School.

She then worked for 9 years at Arkadin, a French Telecom company acquired in 2017 by NTT. She was involved in rapid growth: first in the US managing the customer operations department and integrating 3 acquisitions, then in London in charge of M&A, internal audit and procurement.